NEDD9 overexpression correlates with the progression and prognosis in gastric carcinoma

Medical Oncology

Volumn 31, Issue 3, 2014, Pages

  Shi, Rongfeng ^a   Wang, Lei ^b   Wang, Tao ^c   Xu, Junfei ^a   Wang, Feiran ^a   Xu, Meirong ^a  

^a NANTONG UNIVERSITY   (China)

^b Biotechnologies Nantong Co Ltd   (China)

^c Jiang Xi Chest Hospital   (China)

Author keywords

Gastric cancer; NEDD9; Prognosis

Indexed keywords

MESSENGER RNA; NEDD9 PROTEIN; PROTEIN; UNCLASSIFIED DRUG; NEDD9 PROTEIN, HUMAN; PHOSPHOPROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TUMOR MARKER;

ADULT; ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CANCER STAGING; COMPARATIVE STUDY; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; LOG RANK TEST; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; STOMACH CARCINOMA; TUMOR INVASION; UPREGULATION; WESTERN BLOTTING; ADENOCARCINOMA; DISEASE COURSE; ENZYME IMMUNOASSAY; FOLLOW UP; GENETICS; METABOLISM; METASTASIS; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH; STOMACH TUMOR; SURVIVAL RATE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADENOCARCINOMA; BLOTTING, WESTERN; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM STAGING; PHOSPHOPROTEINS; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STOMACH; STOMACH NEOPLASMS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 84892709818     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-014-0852-4     Document Type: Article

References (34)

1. Jackson CB, Giraud AS. STAT3 as a prognostic marker in human gastric cancer. J Gastroenterol Hepatol. 2009;24:505-7.
2. Howlett M, Menheniott TR, Judd LM, Giraud AS. Cytokine signalling via gp130 in gastric cancer. Biochim Biophys Acta. 2009;1793:1623-33.
3. Ahn HS, Lee HJ, Yoo MW, et al. Changes in clinicopathological features and survival after gastrectomy for gastric cancer over a 20-year period. Br J Surg. 2011;98:255-60.
4. Kumar S, Tomooka Y, Noda M. Identification of a set of genes with developmentally down-regulated expression in the mouse brain. Biochem Biophys Res Commun. 1992;185:1155-61.
5. Law SF, Estojak J, Wang B, Mysliwiec T, Kruh GD, Golemis EA. Human enhancer of filamentation 1 (NEDD9), a novel p130Cas-like docking protein, associates with FAK, and induces pseudohyphal growth in yeast. Mol Cell Biol. 1996;16:3327-37.
6. Seo S, Ichikawa M, Kurokawa M. Structure and function of Cas-L and integrin-mediated signaling. Crit Rev Immunol. 2006;26:391-406.
7. O'Neill GM, Fashena SJ, Golemis EA. Integrin signaling: a new Cas(t) of characters enters the stage. Trends Cell Biol. 2000;10:111-9.
8. Pugacheva EN, Golemis EA. NEDD9-aurora A interactions: points of dialog between the cell cycle and cell attachment signaling networks. Cell Cycle. 2006;5:384-91.
9. Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer. 2002;2:442-54.
10. Thiery JP, Sleeman JP. Complex networks orchestrate epithelial- mesenchymal transitions. Nat Rev Mol Cell Biol. 2006;7:131-42.
11. Thiery JP, Chopin D. Epithelial cell plasticity in development and tumor progression. Cancer Metastasis Rev. 1999;18:31-42.
12. Kelly K, Crowley J, Bunn PA Jr, Presant CA, Grevstad PK, Moinpour CM, Ramsey SD, Woz-niak AJ, Weiss GR, Moore DF, Israel VK, Livings-ton RB, Gandara DR. Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non-small cell lung cancer: a Southwest Oncology Group trial. J Clin Oncol. 2001;19:3210-8.
13. Hennessy BT, Hanrahan EO, Daly PA. Non-Hodgkin lymphoma: an update. Lancet Oncol. 2004;5:341-53.
14. Natarajan M, Stewart JE, Golemis EA, Pugacheva EN, Alexandropoulos K, et al. NEDD9 is a necessary and specific downstream effector of FAK that promotes the migration of glioblastoma cells. Oncogene. 2006;25:1721-32.
15. Kim M, Gans JD, Nogueira C, Wang A, Paik JH, et al. Comparative oncogenomics identifies NEDD9 as a melanoma metastasis gene. Cell. 2006;125:1269-81.
16. Hashemi MR, Rahnavardi M, Bikdeli B, Dehghani Zahedani M, Iranmanesh F. Touch cytology in diagnosing Helicobacter pylori: comparison of fourstaining methods. Cytopathology. 2008;19:179-84.
17. Tian XY, Zhu H, Zhao J, She Q, Zhang GX. Diagnostic performance of urea breath test, rapid urea test, and histology for Helicobacter pylori infection in patients with partial gastrectomy: a meta-analysis. J Clin Gastroenterol. 2012;46:285-92.
18. Liston P, Fong WG, Kelly NL, Toji S, Miyazaki T, et al. Identification of XAF1 as an antagonist of XIAP anti-Caspase activity. Nat Cell Biol. 2001;3:128-33.
19. Shitara K, Mizota A, Yatabe Y, Kondo C, Nomura M, et al. Lapatinib plus trastuzumab for a patient with heavily pretreated gastric cancer that progressed after trastuzumab. Jpn J Clin Oncol. 2011;41(5):663-5.
20. Chua TC, Merrett ND. Clinicopathologic factors associated with HER2-positive gastric cancer and its impact on survival outcomes - a systematic review. Int J Cancer. 2012;130(12):2845-56.
21. Izumchenko E, Singh MK, Plotnikova OV, et al. NEDD9 promotes oncogenic signaling in mammary tumor development. Cancer Res. 2009;69:7198-206.
22. Fidler IJ. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer. 2003;3:453-8.
23. Fashena SJ, Einarson MB, O'Neill GM, Patriotis CP, Golemis EA. Dissection of NEDD9-dependent functions in motility and transcriptional regulation. J Cell Sci. 2002;115:99-111.
24. Seventer GA, Salman HJ, Law SF, et al. Focal adhesion kinase regulates beta1 integrin-dependent T cell migration through an HEF1 effector pathway. Eur J Immunol. 2001;31:1417-27.
25. Dadke D, Jarnik M, Pugacheva EN, Singh MK, Golemis EA. Deregulation of NEDD9 impairs M-phase progression by disrupting the RhoA activation cycle. Mol Biol Cell. 2006;17:1204-17.
26. O'Neill GM, Golemis EA. Proteolysis of the docking protein NEDD9 and implications for focal adhesion dynamics. Mol Cell Biol. 2001;21:5094-108.
27. Simpson KJ, Selfors LM, Bui J, et al. Identification of genes that regulate epithelial cell migration using an siRNA screening approach. Nat Cell Biol. 2008;10:1027-38.
28. Minn AJ, Gupta GP, Siegel PM, et al. Genes that mediate breast cancer metastasis to lung. Nature. 2005;436:518-24.
29. Chung HW, Noh SH, Lim JB. Analysis of demographic characteristics in 3242 young age gastric cancer patients in Korea. World J Gastroenterol. 2010;16:256-63.
30. Kim DY, Joo JK, Ryu SY, et al. Clinicopathologic characteristics of gastric carcinoma in elderly patients: a comparison with young patients. World J Gastroenterol. 2005;11:22-6.
31. Chung HW, Park SW, Chung JB, et al. Differences in genetic expression profiles between young-age and old-age gastric adenocarcinoma using cDNA microarray for endocrine disruptor study. Oncol Rep. 2004;12:33-9.
32. Masuda G, Tokunaga A, Shirakawa T, et al. Helicobacter pylori infection, but not genetic polymorphism of CYP2E1, is highly prevalent in gastric cancer patients younger than 40 years. Gastric Cancer. 2007;10:98-103.
33. Kokkola A, Valle J, Haapiainen R, et al. Helicobacter pylori infection in young patients with gastric carcinoma. Scand J Gastroenterol. 1996;31:643-7.
34. Guerrero MS, Parsons JT, et al. Cas and NEDD9 Contribute to Tumor Progression through Dynamic Regulation of the Cytoskeleton. Genes Cancer. 2012;3(5-6):371-81.